Teleflex Incorporated (NYSE:TFX) Given Average Rating of "Hold" by Brokerages

Teleflex Incorporated (NYSE:TFX - Get Free Report) has been given a consensus rating of "Hold" by the eleven brokerages that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $182.63.

A number of research firms recently weighed in on TFX. Wells Fargo & Company reduced their price target on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Morgan Stanley reduced their price objective on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. Finally, StockNews.com lowered shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th.

Institutional Investors Weigh In On Teleflex

Large investors have recently made changes to their positions in the stock. Vontobel Holding Ltd. boosted its stake in Teleflex by 21.9% during the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock worth $248,000 after buying an additional 250 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Teleflex by 14.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company's stock worth $38,374,000 after acquiring an additional 19,466 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Teleflex by 5.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company's stock valued at $19,263,000 after acquiring an additional 5,322 shares during the last quarter. Lecap Asset Management Ltd. purchased a new stake in shares of Teleflex in the fourth quarter valued at about $729,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock worth $1,053,000 after purchasing an additional 1,527 shares during the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Teleflex Stock Performance

Shares of NYSE:TFX traded down $3.34 during trading on Friday, hitting $127.35. 1,733,672 shares of the stock traded hands, compared to its average volume of 604,779. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a fifty day moving average price of $151.67 and a two-hundred day moving average price of $184.24. Teleflex has a 52-week low of $125.98 and a 52-week high of $249.91. The company has a market cap of $5.90 billion, a price-to-earnings ratio of 25.32, a P/E/G ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, equities analysts predict that Teleflex will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's dividend payout ratio (DPR) is 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.